About Gene Therapy

The goal of gene therapy is to treat or possibly prevent disease. Scientists have been investigating and evolving gene therapy for more than 50 years. One goal of gene therapy research is to determine whether a new or functional gene can be used to restore the function of, or inactivate, a mutated gene.

At Spark Therapeutics, we are using adeno-associated viral (AAV) vectors to advance research programs against strategically selected cell targets, for example, the retina, liver and central nervous system.


About our manufacturing process

Learn more about our in-house, highly specialized manufacturing process that produces the AAV vectors that encapsulate genetic material for the potential treatment of genetic diseases.